Physician profile
Haley Davis
NPI 1689251761
$698.26
in general payments reported to CMS, 2019-2025
8 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $133 · 2023: $50.89 · 2024: $65.74 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $142.68 | 2021 | |
| Abiomed | $134.04 | 2025 | |
| Edwards Lifesciences Corporation | $133.00 | 2022 | |
| Boston Scientific Corporation | $112.15 | 2025 | Lux-Dx Insertable Cardiac Monitor |
| Teleflex LLC | $59.76 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $50.90 | 2023-2024 | Farxiga |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $42.77 | 2023-2024 | Caplyta |
| Haemonetics Corporation | $22.96 | 2024 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.